Investor Information Kit

The information kit provides a comprehensive synopsis of NUCRYST Pharmaceuticals Corp.

If you would like to request an information kit by mail or subscribe to our email distribution list,  click here .

Investor Relations Contact:

MediaProfile
579 Richmond Street West,
Suite 400
Toronto, ON M5V1Y6

Attention: Gillian McArdle
Phone: (416) 342-1813
Fax: (416) 504-4042
Email: info@nucryst.com

• Westaim
• Business Model & Strategy
• Press Releases
• Join Email List